Hubei Haws Medical Co., Ltd., established in 2010, is dedicated to the R&D, production, and sales of new detection technologies and in vitro diagnostic reagents. It boasts an independent innovative technology and excellent manufacturing capabilities, along with a professional R&D, production, management, and operation team. The company has technical platforms in molecular diagnosis, immunology, and POCT. Its product lines encompass various business areas including infectious disease prevention and control, reproductive health testing, genetic disease testing, personalized drug gene testing, and new coronavirus testing, providing comprehensive solutions for healthcare.